Related Experiment Videos

Serial coronary angioplasty for atherosclerosis following heart transplantation

The Journal of Heart Transplantation
|February 1, 1985
PubMed

Insights

Percutaneous transluminal coronary angioplasty successfully treated coronary artery disease in a heart transplant recipient. This minimally invasive procedure offered sustained improvement for graft vasculopathy, demonstrating a viable treatment option.

Area of Science:

  • Cardiology
  • Transplantation Medicine

Background:

  • End-stage ischemic cardiomyopathy necessitates orthotopic heart transplantation.
  • Coronary artery disease (allograft vasculopathy) is a significant long-term complication after heart transplantation.

Observation:

  • A 51-year-old male heart transplant recipient developed severe coronary artery disease (90-95% stenosis) in the allografted heart 46 months post-transplant.
  • Initial percutaneous transluminal coronary angioplasty (PTCA) of the left anterior descending artery lesion resulted in significant stenosis reduction.
  • Follow-up angiography revealed sustained improvement and new lesions, necessitating further PTCA procedures.

Findings:

  • Successful PTCA of proximal and mid-coronary artery lesions in a heart transplant recipient.
  • Demonstrated sustained angiographic improvement at treated sites following PTCA.
  • This case is the first reported instance of coronary angioplasty in a heart transplant patient.

Implications:

  • PTCA is a feasible and effective non-operative treatment for significant coronary artery disease in heart transplant recipients.
  • Minimally invasive revascularization can achieve sustained palliation of allograft vasculopathy.
  • Highlights the potential of interventional cardiology in managing post-transplant cardiac complications.

Related Concept Videos